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Abstract
Objective—Microtia is treated with rib cartilage sculpting and staged procedures; though
aesthetically pleasing, these constructs lack native ear flexibility. Tissue-engineered (TE) elastic
cartilage may bridge this gap; however, TE cartilage implants lead to hypertrophic changes with
calcification and loss of flexibility. Retaining flexibility in TE cartilage must focus on increased
elastin, maintained collagen II, decreased collagen X, with prevention of calcification. This study
compares biochemical properties of human cartilage to TE cartilage from umbilical cord
mesenchymal stem cells (UCMSCs). Our goal is to establish a baseline for clinically useful TE
cartilage.
Methods—Discarded cartilage from conchal bowl, microtic ears, pre-auricular tags, rib, and TE
cartilage were evaluated for collagen I, II, X, calcium, glycosaminoglycans, elastin, fibrillin I and
III. Human UCMSCs were chondroinduced on 2-D surfaces and 3-D D, L-lactide-co-glycolic acid
(PLGA) fibers.
Results—Cartilage samples demonstrated similar staining for collagens I, II, X, elastin, fibrillin
I, and III, but differed from rib. TE pellets and PLGA-supported cartilage were similar to auricular
samples in elastin and fibrillin I staining. TE samples exclusively stained for fibrillin III. Only
microtic samples demonstrated calcium staining.
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Conclusions—TE cartilage expressed similar levels of elastin, fibrillin I, collagens I and X
when compared to native cartilage. Microtic cartilage demonstrated elevated calcium, suggesting
this abnormal tissue may not be a viable cell source for TE cartilage. TE cartilage appears to
recapitulate the embryonic development of fibrillin III, which is not expressed in adult tissue,
possibly providing a strategy to control TE elastic cartilage phenotype.
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Introduction
Microtia is a deformity of the external auricle, which presents in .843 to 4.34 cases in 10,000
live births 1. Because microtia is a noticeable physical deformity, it can have a detrimental
impact on a child’s psychosocial well-being and development. Children with microtia
become self-aware of the malformation at the ages 5 to 6 and have been shown to be at a
higher risk for interpersonal difficulties, depression, and aggression/hostility2. Treatments
for microtia utilize endogenous costal cartilage grafts or synthetic implants. In costal
cartilage implantation, techniques typically performed are ones popularized by Brent,
Nagata, and Firmin3. These surgical techniques involve rib cartilage harvest and sculpting,
with implantation, followed by staged surgeries to create the semblance of an external ear 4.
Risks associated with harvest include pneumothorax, chest wall retrusion, and postoperative
thoracic scoliosis; risks associated with the implant site include infection, extrusion, and loss
of the graft5. While the reconstructed ear may be aesthetically pleasing, 6 costal cartilage (a
hyaline cartilage) does not have the same deformability as native auricular tissue.
Alternatives to autologous cartilage include synthetic implants, such as Medpor®, but have
higher risks of infection and extrusion, while still lacking the deformability of native
auricular tissue 7. Solutions to these limitations noted in both autologous and synthetic ear
reconstruction may be found in tissue-engineered (TE) cartilage. The potential advantages of
TE cartilage constructs include an unlimited supply of engineered cartilage, fewer surgeries,
and the avoidance of attendant complications. However, to date, the major limitation to TE
cartilage is that it tends to calcify, and become inflexible in a predictable fashion after
implantation 8. From a clinical standpoint, TE elastic cartilage must maintain its elastic
phenotype, have characteristics that allow ear flexibility, and yet, must be rigid enough to
withstand the deforming forces of the healing soft tissue envelope.
In previously published work, our laboratory has utilized human umbilical cord
mesenchymal stem cells (hUCMSCs) as a cell source for TE cartilage 9. Nanofiber-
supported hUCMSC chondrogenesis promoted increased glycosaminoglycans (GAG) and
improved collagen II to I ratio (differentiation index) compared to standard pellet formation,
indicating an elastic cartilage phenotype 10. However, we also noted increased expression of
collagen X, and decreased expression of elastin mRNA, both of which suggest the
development of a hypertrophic cartilage phenotype. Because hypertrophic cartilage tends to
be less flexible, and may indicate a tendency to calcify after implantation, we wanted to
further evaluate our tissue-engineered cartilage in comparisons to normal auricular cartilage
(conchal bowl), pre-auricular cartilage remnants, microtia samples, and hyaline cartilage
from rib, which is the current gold standard for cartilage source during external ear
reconstruction.
In order to create and maintain flexible TE elastic cartilage beyond our current capabilities,
we need to maintain control over elastic fiber deposition, fibrillin production, eliminate
calcium deposition, and diminish collagen X production. Elastic fibers are formed when
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tropoelastin binds to fibrillin I in the ECM and becomes cross-linked11. As such,
maintaining fibrillin I content in tissue engineered cartilage provides the appropriate
template for elastin deposition and cross-linking, thereby maintaining tissue engineered
cartilage flexibility. In addition to fibrillin I, two other types of fibrillin have been identified.
Fibrillin II is expressed with fibrillin I prenatally, and is only minutely expressed in mature
tissues 12. Fibrillin III is expressed prenatally and no longer present following birth13. To
our knowledge fibrillin expression in TE cartilage has not been characterized and may
eventually provide insight into maintaining elastic cartilage phenotype following
implantation.
Elastic cartilage flexibility also decreases as calcium deposition in the matrix increases14.
Calcium cross-links to binding domains in fibrillin, making the fibrillin template inflexible;
therefore, minimizing calcium matrix deposition is another strategy to maintain cartilage
flexibility. A last set of strategies to prevent phenotype change from elastic cartilage to
hypertrophic cartilage is to control the presence of certain collagens, namely, to maintain a
differentiation index (collagen II/I ratio) above 1 (with greater collagen II); a ratio below 1 is
an indication of fibrocartilage development, and to control the collagen X content of the
cartilage. Increased collagen X is an initial indication that hypertrophic cartilage is
developing.
Lastly, MSC source may play a role in maintaining an elastic cartilage phenotype. To date,
abdominal adipocytes have proven to be the most reliable source for adult tissue-
engineering15. In infants and children, minimal sources of fat exist for harvesting, making
this a less than ideal cell source. Other discarded tissue sources–including cartilage itself--
may be useful to generate TE elastic cartilage, including pre-auricular cartilage-skin
remnants, microtic cartilage harvested at the time of staged ear reconstruction, and rib
cartilage. In order to determine whether a cell source is a legitimate alternative for TE
cartilage, the biochemical properties of these sources must be determined.
The goal of this study is to accurately define the expression of various extracellular matrix
(ECM) components in auricular cartilage, including collagen I, II, X, calcium;
glycosaminoglycans (GAGS), elastin, fibrillin I and II. We wish to compare our tissue
engineered pellets and nanofiber--supported TE cartilage to these tissues to determine a
baseline of understanding how to create and maintain elastic cartilage phenotype in TE
cartilage.
Materials/Methods
Discarded human cartilage samples were collected with IRB approval (IRB # 10-1580
and 10-1299) and included conchal bowl, microtia, pre-auricular skin and cartilage
remnants, and rib cartilage. Samples were fixed in 10% formalin solution up to 48 hours and
stored in 70% ethanol before biochemical characterization.
Tissue engineered cartilage was generated from hUCMSCs harvested using an explant
technique. Passage 2 cells were chondroinduced as previously described 9. Briefly, 4 × 105
isolated hUCMSCs were placed in 0.3 mL of chondrogenic media in a 2 mL conical tube
and grown for 21 days, after which the pellet was fixed in 10% formalin and frozen. PLGA
nanofibers were electrospun as mats as previously described16. 4 × 105 hUCMSCs were
seeded on the nanomats and subjected to chondrogenesis for 21 days, after which, scaffolds
were fixed in 10% formalin solution up to 48 hours and stored in 70% ethanol before
biochemical characterization.
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Mouse monoclonal anti-Collagen I, II and X antibodies were purchased from Abcam
(Cambridge, MA). Rabbit polyclonal anti-Fibrillin I was obtained from Sigma-Aldrich (St.
Louis, MO); goat polyclonal anti-Fibrillin III was obtained from Santa Cruz Biotechnology
(Santa Cruz, CA).
Chondrocyte cultures and human samples were fixed in neutral-buffered formalin for 24
hours and stored in 70% ethanol for staining. Samples were paraffin embedded; 4 μm
sections were cut with a microtome. IHC was performed in a Bond Autostainer (Leica
Microsystems Inc. Norwell, MA). Slides were de-waxed in Bond Dewax solution (AR9222)
and hydrated in Bond Wash solution (AR9590). Antigen retrieval for collagen I and X and
fibrillin I antibodies was performed for 15 min at 37° C in Pepsin (Invitrogen; Camarillo,
CA). Collagen II antigen retrieval was performed using the Bond Enzyme Pretreatment kit
(AR9551); no antigen retrieval was necessary for fibrillin III. Detection of the collagen I, II,
X and fibrillin I antibodies was performed using the Bond Polymer Refine Detection System
(DS9800). For fibrillin III the secondary antibody and polymer from the kit were replaced
by Goat IgG and the HRP polymer from Biocare (Concord, CA). Stained slides were
dehydrated and prepared with a coverslip. Positive and negative controls were included for
each antibody.
Histological Stains
Elastin was detected using the Verhoeff Elastic Stain kit (KTVEL); calcium was detected
with the Alizarin Red Stain kit (STARE; American MasterTech; Lodi, CA).
Digital imaging and image analysis
Stained slides were digitally imaged at 20× magnification using the Aperio ScanScope XT
(Aperio Technologies, Vista, CA). Digital images were stored and analyzed within the
Aperio Spectrum Database. Expression levels of biomarkers were measured using the
Aperio Color Deconvolution V9 algorithm with minor modifications. Optical densities and
intensity thresholds were modified based on levels in positive and negative controls. The
percent area with strong (+3), medium (+2) and weak (+1) positive signals, as well as total
positive signal, were used to compare biomarker levels.
Results
Cartilage from conchal bowl, preauricular remnants, microtic, and TE samples (pellets
grown on 2-D surfaces, and PLGA-supported cartilage) stained in similar distributions for
collagen I and X; however, costal cartilage stained less intensely for both (Figure 1).
Conchal bowl and preauricular cartilage remnants stained similarly for collagen II; microtic
cartilage stained less positively; both costal and TE cartilage stained lightly for collagen II.
Alizarin red stain was negative in all samples, with the exception of microtia samples, where
calcium was noted in the extracellular matrix. All of the human cartilage samples
demonstrated similar percentage of cells positive for collagen II (Table 1); the TE pellet
(45%) and PLGA cartilage (63%) stained less intensely for collagen II. Collagen X was
expressed similarly in native tissues (>95%) but were below 91% in both TE pellets and
PLGA-supported cartilage.
All native tissues demonstrated similar extracellular glycosaminoglycan by alcian blue
staining (Figure 2); the pellet and PLGA samples stained less intensely, but were uniformly
positive. Native auricular cartilage (conchal bowl, preauricular tags, microtia sample)
stained similarly for elastin, with less intense staining noted in TE cartilage and none in
costal cartilage. Fibrillin I stains were similar in all stained tissue samples, with the
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exception of costal cartilage, where staining was lighter. All native cartilage types stained
negative for fibrillin III; however, both TE cartilage samples were positive for this immature
fibrillin.
Elastin staining in cartilage from the conchal bowl, microtia, and preauricular cartilage were
similar to the TE pellet, but higher than the PLGA-supported cartilage and rib cartilage
(Table 2). Fibrillin I stain quantification was similar in the native auricular samples (> 96%
positive), lower in the TE cartilage samples (90%) and lowest in rib cartilage (41%).
Fibrillin III stain was minimally present in conchal bowl, preauricular, and microtic
cartilage, and absent in rib cartilage. Both the TE pellets (55%) and PLGA-supported
cartilage (92%) demonstrated extensive fibrillin III staining.
Discussion
TE elastic cartilage is a potential solution for current limitations in microtia reconstruction.
This cartilage will overcome the rigidity and lack of deformability of the reconstructed ear
seen in both costal cartilage and synthetic implant strategies, eliminate the surgical risks
associated with rib harvest, and result in a non-immunogenic construct. However, before
clinical utility can be established, there must be demonstration that this cartilage is
phenotypically similar to native auricular cartilage, and will maintain an elastic cartilage
phenotype when implanted. Because conchal cartilage is the true normal in our set of
comparisons, initial comparisons need to be established between TE and conchal cartilage.
Both of the TE cartilage samples (2-D and PLGA supported) expressed similar levels of
collagen I, X, and fibrillin I compared to conchal bowl cartilage. However, some notable
differences also existed, including lower levels of elastin and collagen II in the PLGA
nanofiber-supported cartilage. Both of these findings will eventually need to be remedied in
our TE cartilage prior to implantation.
An interesting finding in TE cartilage is the presence of fibrillin III (to the best of our
knowledge, ours is the first report of this immature fibrillin in TE cartilage). Lower levels of
elastin in the TE PLGA-supported cartilage may in part be explained by the immaturity of
TE cartilage, demonstrated by the presence of fibrillin III. The TE cartilage pellet exhibited
55% fibrillin III positivity, while PLGA-supported TE cartilage exhibited higher positivity
(92%), indicating that the TE cartilage is more primitive, and may have similarities to pre-
natal cartilage. In the human embryo, fibrillin III is thought to be instrumental in the initial
formation of microfibril elastic cores; fibrillin III then disappears during maturation of the
embryo, and fibrillin I becomes the primary extracellular matrix protein for elastic
microfibrils17. In order for this fibrillin III to convert to fibrillin I, TE cartilage may need to
be housed in vitro for longer time periods, or may need to be reassessed following
implantation. Further studies are required to determine if fibrillin III expression in TE
cartilage changes over time. While 40 weeks (analogous to human gestation) is probably not
needed for maturation of in vitro-generated TE cartilage, time periods greater than the
current 21 days will likely be required13.
Further indication of the immaturity of the TE cartilage can be seen in the relative
distribution of collagen I and II in both the nanofiber construct and pellet. In mature
cartilage, collagen I is normally expressed by chondrocytes in a thin layer covering the
surface, whereas collagen II is expressed more interiorly. However, seen in the staining of
the both the nanofiber-supported and pellet TE cartilage, collagen I seems to not only be
expressed by chondrocytes in the periphery, but also throughout the entirety of the construct.
The collagen II-producing chondrocytes are found in a central location, as would be
expected in native cartilage. The wide distribution of collagen I is a possible indication of
TE cartilage immaturity. This hypothesis is further strengthened because the staining pattern
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of the PLGA and pellet constructs seems to more closely resemble the preauricular cartilage
remnants (a more immature cartilage) than the conchal bowl staining.
A second goal of this work was to assess potential cell sources for the purpose of
engineering elastic cartilage. The most readily available sources, in descending order, are
preauricular cartilage remnants (generally excised and discarded, and often done at an early
age), microtic cartilage (easily accessible during surgery for microtia repair and discarded),
rib cartilage (potentially discarded after multiple procedures, including microtia repair), and
normal ears (rarely discarded). Histological staining of these native cartilage sources
reinforces the known differences between costal (hyaline cartilage) and auricular cartilage
(elastic cartilage)18. Elastic cartilage 19 is populated with larger chondrocytes, higher
expression of ECM components, specifically elastin and collagen II, and faster proliferation
in vitro 20. The use of rib cartilage as a stem cell source for auricular chondrocytes would be
expected to lead to insufficient elastic generation, and secondarily to an incorrect collagen II
to I ratio. This is supported by work with bovine chondrocytes harvested from several
anatomical locations, including costal cartilage. These cells were seeded on poly (l-lactide-ε-
caprolactone) scaffolds, and implanted for 40 weeks in nude mice. At study completion, the
costal chondrocyte scaffold was rigid, exhibiting calcified nodules21, and did not appear to
be suitable for generating elastic cartilage.
Conchal, preauricular, and microtia cartilage samples all exhibited similar staining for
elastin, fibrillin I and III, as well as collagen I and II. Microtic cartilage was the only
cartilage sample, however, that stained positive for calcium, suggesting abnormalities in this
cartilage that make unsuitable as a stem cell source for TE cartilage. Among these samples,
the best source for TE cartilage may be preauricular cartilage remnants (given the similarity
in staining patterns to conchal cartilage, a relatively high incidence among patients (which
may be as high as 1% of the population)22, and the fact that they are surgically excised
relatively early in life and discarded). Preauricular cartilage also expressed a higher fibrillin
III level among the endogenous cartilage tested, suggesting that it may represent an
immature auricular cartilage, which could be advantageous for TE cartilage. However, the
amount of cartilage present within the preauricular remnants is variable (sometimes absent
altogether) which presents a challenge as a cartilage cell source.
The umbilical cord as a discarded source of MSCs capable of undergoing chondrogenesis
appears to be an ideal source of stem cells for TE cartilage but there continue to be
biochemical hurdles that must be overcome in order to replicate normal auricular cartilage
including maintaining Collagen II/I ratio above one, controlling elastin and fibrillin content,
minimizing collagen X content and preventing calcium deposition.
Summary
TE cartilage using hUCMSCs on PLGA nanofiber-supported scaffolds results in cartilage
that is similar to conchal bowl in staining for collagen I, X, and fibrillin I. However, elastin
and collagen II expression levels are lower and the presence of fibrillin III suggests
immaturity. TE cartilage needs to have higher levels of elastin and collagen II, lower levels
of fibrillin III and be less deformable in order to justify use in microtia repair. An on-going,
and unanswered question regarding TE cartilage, is how to find a balance between the needs
for construct flexibility and a sufficient rigidity to withstand the deforming forces of the
overlying skin envelope. Though this study sets the stage for creating a flexible elastic
cartilage phenotype, significant further studies will be required to determine efficacy in vivo.
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Histochemical analysis of cartilage. Images are representative of collagen I, II, X, and
alizarin red staining for calcium of frozen adult conchal bowl, pediatric microtia, pediatric
preauricular cartilage remnants, and adult costal cartilage. Similar distributions of collagens
I, II, and X were seen in all samples, with the exception of rib cartilage (a hyaline cartilage).
Calcium was present in only the microtia samples. The TE pellet and PLGA –supported
cartilage demonstrated similar distribution of Collagen I, X, and calcium in the extracellular
matrix as native auricular cartilage. Collagen II distribution was less than native auricular
cartilage samples, but greater than rib.
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Histochemical analysis of cartilage. Images are representative of alcian blue, elastin, fibrillin
I, and III staining of frozen adult conchal bowl, pediatric microtia, pediatric preauricular
cartilage remnants, and adult costal cartilage. All samples demonstrated glycosaminoglycans
in the extracellular matrix. The TE and auricular cartilage showed similar elastin and
fibrillin I distributions, with rib minimally demonstrating these proteins. Fibrillin III was
positively expressed in TE samples, while not present in endogenous tissues.
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Table 1
Semi-quantitative image analysis of collagens I, II, X, and calcium deposition. Total positivity of stains was
analyzed using Spectrum software. Positivity was designated as strong, medium, or weak, depending on the
intensity/darkness of each pixel. Similar distributions were seen in the TE (both pellet and PLGA-supported
cartilage) and auricular-derived cartilage for collagens I and X, with marginal presence in rib samples. The
microtia samples had a significantly higher presence of calcium, unlike the other samples. Collagen II was
most intense in auricular-derived cartilage, lower in the TE cartilage, and nearly absent in rib samples.
Stain Tissue % Positive %Strong+ %Medium+ % Weak+
Collagen I
Conchal bowl 99 66 29 4
Microtia 99 63 28 8
Preauricular Tag 100 84 14 2
Rib 93 0 21 72
Pellet 91 32 39 20
PLGA 92 26 42 24
Collagen II
Conchal bowl 97 23 50 23
Microtia 90 9 45 36
Preauricular Tag 96 26 49 22
Rib 3 0 1 2
Pellet 45 0 12 33
PLGA 63 3 21 39
Collagen X
Conchal bowl 100 53 41 6
Microtia 99 14 62 23
Preauricular Tag 99 17 57 25
Rib 95 6 19 69
Pellet 91 21 40 31
PLGA 90 17 38 34
Alizarin Red
Conchal bowl 0 0 0 0
Microtia 4.14 0.55 1.18 2.40
Preauricular Tag 0.28 0 0.01 0.27
Rib 0.85 0.02 0.11 0.72
Pellet 0.01 0 0 0.01
PLGA 0.02 0 0 0.02
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Table 2
Semi-quantitative image analysis of elastin, fibrillin I, and III. Total positivity of the stain was analyzed using
Spectrum software. Positivity was then quantitated as strong, medium, or weak, depending on intensity/
darkness of each pixel. Increased elastin and fibrillin I were seen in all samples, with the exception of rib
cartilage. Fibrillin III was present in the TE samples (PLGA-supported greater than pellet), with absent
staining in endogenous tissues.
Stain Tissue % Positive %Strong+ %Medium+ % Weak+
Elastin
Conchal bowl 49 1 18 29
Microtia 47 1 15 31
Preauricular Tag 38 1 11 26
Rib 10 2 3 5
Pellet 48 2 14 32
PLGA 30 1 5 25
Fibrillin I
Conchal bowl 97 26 46 24
Microtia 96 22 47 27
Preauricular Tag 99 48 41 10
Rib 41 1 12 27
Pellet 89 29 39 22
PLGA 90 23 42 24
Fibrillin III
Conchal bowl 1 0 0 1
Microtia 5 0 1 4
Preauricular Tag 7 0 0 7
Rib 0 0 0 0
Pellet 55 6 20 29
PLGA 92 11 50 30
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